Azathioprine Alternatives Compared
Azathioprine | Vedolizumab | Upadacitinib |
|
---|
Azathioprine | Vedolizumab | Upadacitinib |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Autoimmune Hepatitis, Atopic Dermatitis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Behcet's Disease, Bullous Pemphigoid, Chronic Active Hepatitis, Cogan's Syndrome... View more |
Prescription only
Prescribed for Ulcerative Colitis, Crohn's Disease - Maintenance, Crohn's Disease. vedolizumab may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Crohn's Disease, Ankylosing Spondylitis, Atopic Dermatitis, Non-Radiographic Axial Spondyloarthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Rheumatoid... View more |
Related suggestions Ulcerative Colitis
Crohn's Disease
|
|||||||
More about Azathioprine | More about Vedolizumab | More about Upadacitinib | ||||||||
Ratings & Reviews | ||||||||||
Azathioprine has an average rating of 6.1 out of 10 from a total of 127 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 32% reported a negative effect. |
Vedolizumab has an average rating of 6.2 out of 10 from a total of 176 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 28% reported a negative effect. |
Upadacitinib has an average rating of 6.8 out of 10 from a total of 191 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: azathioprine side effects in more detail. |
See also: vedolizumab side effects in more detail. |
See also: upadacitinib side effects in more detail. |
||||||||
Generic Availability | ||||||||||
Lower cost generic |
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
View all azathioprine prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms Available | ||||||||||
|
N/A |
N/A |
||||||||
Brand Names | ||||||||||
Azasan, Imuran | Entyvio, Entyvio Pen | Rinvoq, Rinvoq LQ | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
2 hours |
600 hours |
14 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 426 drugs are known to interact with azathioprine:
|
A total of 157 drugs are known to interact with vedolizumab:
|
A total of 586 drugs are known to interact with upadacitinib:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
March 20, 1968 |
May 20, 2014 |
August 16, 2019 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.